Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
77.2M
-
Shares change
-
-617K
-
Total reported value, excl. options
-
$613M
-
Value change
-
-$47.9M
-
Put/Call ratio
-
0.27
-
Number of buys
-
107
-
Number of sells
-
-65
-
Price
-
$7.95
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2019
213 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q2 2019.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 77.2M shares
of 117M outstanding shares and own 66.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (6.57M shares), BlackRock Inc. (5.07M shares), JPMORGAN CHASE & CO (4.77M shares), DIMENSIONAL FUND ADVISORS LP (3.65M shares), RIVERBRIDGE PARTNERS LLC (3.4M shares), CREDIT SUISSE AG/ (3.25M shares), GLENMEDE TRUST CO NA (2.77M shares), Bellevue Group AG (2.35M shares), Standard Life Aberdeen plc (2.19M shares), and Elk Creek Partners, LLC (2.17M shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.